These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 467854

  • 1. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E, Sarantakis D.
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [Abstract] [Full Text] [Related]

  • 2. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL.
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [Abstract] [Full Text] [Related]

  • 3. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE, Efendić S, Meyers CA, Coy DH, Schally A, Luft R.
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [Abstract] [Full Text] [Related]

  • 4. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R, Verdonk C, Miles J, Service FJ, Gerich J.
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [Abstract] [Full Text] [Related]

  • 5. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL, Garsky VM.
    Horm Metab Res; 1981 Dec; 13(12):675-8. PubMed ID: 6119282
    [Abstract] [Full Text] [Related]

  • 6. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats.
    Karashima T, Schally AV.
    Peptides; 1988 Dec; 9(3):561-5. PubMed ID: 2901737
    [Abstract] [Full Text] [Related]

  • 7. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A, Meyers C, Arimura A, Coy DH, Schally AV.
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [Abstract] [Full Text] [Related]

  • 8. Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide.
    Pettersson M, Ahrén B.
    Regul Pept; 1988 Oct; 23(1):37-50. PubMed ID: 2907171
    [Abstract] [Full Text] [Related]

  • 9. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A, Märki F, Keller U.
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [Abstract] [Full Text] [Related]

  • 10. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M, Massara F, Camanni F, Molinatti GM, Lorenzati R, Pagano GF.
    J Endocrinol Invest; 1980 Aug; 3(2):189-92. PubMed ID: 6104680
    [Abstract] [Full Text] [Related]

  • 11. Prolonged suppression of insulin release by a somatostatin analog.
    Lien EL, Garsky VM.
    Endocrinology; 1978 Jul; 103(1):81-5. PubMed ID: 744088
    [Abstract] [Full Text] [Related]

  • 12. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F, Kamber B, Rink H, Sieber P.
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [Abstract] [Full Text] [Related]

  • 13. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS, Hendler R, DeFronzo R, Wahren J, Felic P.
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [Abstract] [Full Text] [Related]

  • 14. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE, Perfetti MG, Andreotti AC, Fattor B, Monti LD, Pozza G.
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [Abstract] [Full Text] [Related]

  • 15. Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat.
    Kuku SF, Jaspan JB, Emmanouel DS, Katz AI, Rubenstein AH.
    Horm Metab Res; 1978 Mar; 10(2):99-100. PubMed ID: 649048
    [Abstract] [Full Text] [Related]

  • 16. Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.
    Klaff LJ, Taborsky GJ.
    Am J Physiol; 1987 Jun; 252(6 Pt 1):E751-5. PubMed ID: 2884887
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H, Anderson JR, Sigel MB, Yen SS.
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [Abstract] [Full Text] [Related]

  • 18. Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men.
    Gonzalez-Barcena D, Mendoza F, Medina R, Coy DH, Murphy WA, Schally AV.
    Endocr Res; 1984 Apr; 10(1):39-48. PubMed ID: 6146518
    [Abstract] [Full Text] [Related]

  • 19. Influence of arginine on splanchnic glucose metabolism in man.
    Bratusch-Marrain P, Björkman O, Hagenfeldt L, Waldhäusl W, Wahren J.
    Diabetes; 1979 Feb; 28(2):126-31. PubMed ID: 421970
    [Abstract] [Full Text] [Related]

  • 20. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G, Lickley L, Vranic M.
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.